Popular Articles
Grapefruit Benefits

Lobbyists Face Potential Conflicts Of Interest
"With a health reform at the top of the Congressional and White House agenda, it"s prime time for industry lobbyists," Roll Call reports. But, because details of the anticipated reform package have not yet emerged, industry winners and losers remain largely unknown. Lobbyists are forced to accept clients despite their incomplete knowledge of client needs, and are struggling to anticipate conflicts of interest before they arise, according to the article. "There are so many different players at the table, and right now not knowing whose ox is likely to get gored and at whose expense... the best we can do is try and anticipate conflicts and be clear with our clients in advance," one health care lobbyist told the paper. "We certainly would not lobby on both sides of an issue. It"s also entirely possible conflict may emerge in the next two to six months, and we hope we don"t have to make hard choices" (Ackley, 6/3).
generic viagra online
Reduced-Dose Schedule For Pneumococcal Vaccine In Infants Shows Effectiveness
Infants who received two or three primary doses of the 7-valent pneumococcal conjugate vaccine (PCV-7) both had a decreased rate of carrying pneumococcal microorganisms that can cause pneumonia and other infections, compared to infants who were not vaccinated, according to a study in the July 8 issue of JAMA.
News of the day
The Obama Administration Ramps Up Push For Health Care Reform
The Obama administration ramps up efforts to promote health care reform and reacts to a sobering announcement by the Congressional Budget Office about the scoring of a health care bill.
Sexual Health

The Birth Of A Synapse

Researchers have identified the locking mechanism that allows some neurons to form synapses to pass along essential information. Mutations of genes that produce a critical cell-adhesion molecule involved in the work were previously linked to autism. The discovery - captured with fluorescent imaging of excitatory neurons harvested from rat pups shortly after birth and studied in culture as they continued to develop - is described in a paper placed online May 18 ahead of formal publication in the open-access journal Neural Development. "We"ve caught two neuronal cells in the act of forming a synapse," said principle investigator Philip Washbourne, professor of biology at the University of Oregon. He describes the cell-adhesion neuroligin proteins on the membranes of receptor neurons as "molecular Velcro." The research team of six UO and University of California, Davis, scientists found one of many finger-like filopodia, or spines, that reach out from one neuron is nabbed by neuroligin molecules on the membrane of another neuron. In turn, neuroligins recruit at least two other key proteins (PSD-95 and NMDA receptors) to begin building a scaffold to hold the synapse components in place. The moment of locking is captured in a video that will appear with the paper"s final version at the journal"s Web site. Two neuroligin family members (3 and 4) have been linked to autism in the last decade. "Chemical synapses are the primary means for transmitting information from one neuron to the next," said Washbourne, who is a member of the UO"s Institute of Neuroscience. "Synapses are initially formed during development of the nervous system, and formation of appropriate synapses is crucial for establishing neuronal circuits that underlie behavior and cognition. Minor irregularities can lead to developmental disorders such as autism and mental retardation, and they may contribute to psychological disorders." The findings, he added, reflect a clearer understanding of how synapses form, providing a roadmap for research that someday may lead to new therapies or a cure for autism, a brain development disorder that affects a person"s social and communication abilities. The disorder affects 1 in every 150 American children, according to the Autism Society of America. The new window opened by Washbourne"s team captures the essence of synapse development, which occurs over and over among the estimated 100 billion neurons that make some 100 trillion synapses in a single human being. That leaves a lot of room for errors in the DNA-driven instructions for synthesizing molecules responsible for synapse formation, Washbourne said. "Basically," Washbourne said, "we have found mechanisms by which two very important molecules, NMDA and PSD-95, are brought to a newly forming synapse." Co-authors with Washbourne were postdoctoral researches Stephanie L. Barrow and Eliana Clark at UC-Davis, A. Kimberley McAllister, a professor in the UC-Davis Center for Neuroscience, and John R.L. Constable, a postdoctoral researcher in Washbourne"s UO lab. Constable is funded by a medical research fellowship provided by Oregon Health and Science University in Portland. The National Institute of Neurological Disorders and Stroke (National Institutes of Health), the Florida-based non-profit Whitehall Foundation and New York-based Autism Speaks, the nation"s largest autism science and advocacy organization, funded Washbourne"s research. McAllister was funded by the Pew Charitable Trusts and National Eye Institute. Jim Barlow University of Oregon


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):